- 胆素轴有助于胰腺癌细胞中的铁衰抵抗
Arslan Amer1, Micah Idowu1, Aqsa Ahsan1
1Department of Biological Sciences, Michigan Technological University, Houghton, MI 49931, USA.
International journal of molecular sciences
|February 27, 2026
概括
胰腺癌细胞对铁亡的反应各异. 一个独立于GPX4的-硫素通路,在上皮细胞中赋予了抵抗力,这表明了新的治疗标.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 胰腺管腺癌 (PDAC) 在囊依赖性和铁亡敏感性方面表现出显著的异质性.
- 两个PDAC亚型,介质类和上皮类,表现出明显的脆弱性和抵抗机制.
- 目前对PDAC中铁灭菌耐药性的理解需要进一步阐明潜在的途径.
研究的目的:
- 为了研究表皮类型PDAC细胞中铁灭性抵抗的机制.
- 确定新的途径,有助于超越谷氨过氧化酶4 (GPX4) 的铁灭菌耐药性.
- 探索和硫素还原酶在PDAC铁亡中的作用.
主要方法:
- 基于表皮层-介质细胞过渡 (EMT) 状态的PDAC亚型的比较分析.
- 在囊剥夺或系统xc-抑制时评估铁亡的敏感性.
- 对补充对铁和谷 (GSH) 水平的影响的评估.
- 研究氨酸减少酶 (TrxR1和TrxR2) 抑制对铁灭症敏感性和保护的作用.
主要成果:
- 类似介质细胞的PDAC细胞依赖氨酸,对铁亡敏感,而上皮类型的细胞则具有抗性.
- 补充剂可以独立于GPX4和GSH水平,防止铁亡.
- 皮质类型的细胞利用TrxR1和TrxR2进行铁灭抵抗.
- 氨酸减少酶的抑制取消了介导的保护,并使细胞对铁灭菌敏感.
结论:
- 一个独立于GPX4的新型-硫氧化氧还原轴,在上皮类型PDAC中赋予铁灭菌耐药性.
- 向囊代谢和硫素减少酶为抗性PDAC亚型提供了潜在的治疗策略.
- 了解PDAC异质性对于开发有效的基于铁灭的癌症疗法至关重要.
相关概念视频
Electron Transport Chain: Complex I and II
19.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Necrosis
6.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.9K
